For instance, a more diverse range of chemotherapeutic drugs should be used to assess the impact of LMAN2 on chemotherapy resistance in BC cell lines, and inhibitory reagents can be used to scrutinize the effects of LMAN2 on the associated signaling pathways. The gene discussed is LMAN2; the disease is breast cancer.